A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
About this item
Full title
Author / Creator
Sanyal, Arun J. , Bedossa, Pierre , Fraessdorf, Mandy , Neff, Guy W. , Lawitz, Eric , Bugianesi, Elisabetta , Anstee, Quentin M. , Hussain, Samina Ajaz , Newsome, Philip N. , Ratziu, Vlad , Hosseini-Tabatabaei, Azadeh , Schattenberg, Jörn M. , Noureddin, Mazen , Alkhouri, Naim , Younes, Ramy and 1404-0043 Trial Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this phase 2 trial involving adults with metabolic dysfunction–associated steatohepatitis and liver fibrosis, survodutide was superior to placebo with respect to improvement in MASH without worsening of fibrosis.
Alternative Titles
Full title
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3065979425
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3065979425
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2401755
